Andrographis Paniculata: A Potential Ally in COVID-19 Management?

The role of Andrographis paniculata in combating COVID-19 has been a subject of interest in the scientific community. Andrew Weil, M.D., in his article dated September 10, 2021, sheds light on this traditional herb's potential in this context.

• Overview: Andrographis paniculata, native to Southeast Asia, is known for its antiviral properties, commonly used for colds and throat infections.

• Usage Recommendation: Weil suggests a 400 mg standardized extract of Andrographis twice daily during the cold and flu season to reduce virus contraction risk.

• Safety and Potential Benefits: The herb is considered safe and may offer benefits against COVID-19, though its efficacy against this specific virus remains unproven.

• Literature Review: A 2020 review in Frontiers in Pharmacology evaluated various herbal remedies for their effectiveness in treating mild COVID-19 symptoms. Andrographis was among the 12 herbs categorized as 'promising'.

• Specific Studies:

  • Frontiers in Pharmacology: This study categorized 39 herbs based on their efficacy against respiratory symptoms, with Andrographis being promising​​.

  • Journal of Natural Products: A different study focused on Andrographis's anti-SARS-CoV-2 properties in human lung cells, supporting its potential in addressing COVID-19​​.

• Clinical Trials: Despite promising preclinical results, the lack of published clinical trial outcomes for Andrographis in the context of COVID-19 makes these findings preliminary.

• Self-Care Recommendations: Alongside Andrographis, Weil recommends other natural products like garlic and quercetin for immune support, emphasizing the importance of hydration, rest, and isolation in managing mild COVID-19 symptoms at home.

For more detailed information, you can read the full article by Andrew Weil, M.D. here.